U.S, February 10, 2020 (GREENMARKETREPORT) Cannabis, to some, is seen as a risky market. Bankers, the government, and society, in general, all have their own hesitations with the industry. This rings true for investors, too. FINANCIAL-investors-tell-cannabis-companies-prove-it-before-opening-wallet
Some financial experts are adamant about the importance...
CANADA, February 4, 2020 (HEMPINDUSTRY) Editor’s note: This is part of an occasional series on retailing trends in the hemp industry.
Canada’s federal health regulator is reviewing the potential market for cannabis health products that would not require physician oversight, a review that...
CANADA, November 25, 2019 (BOTANIQMAG) According to Statistics Canada, there are 811,000 Canadians taking recreational or illegal cannabis products for their health without a doctor’s note or prescription.
“These are not products that have been approved by Health Canada as over-the-counter medicines (OTCs) or natural health products (NHPs),” notes a...
U.S, February 12, 2020 (CANNABISTECH) Solving bioavailability issues with cannabinoids, nanoemulsion technology and ultrasonic techniques increase product effectiveness.
Cannabis has always had an issue with bioavailability. Whether smoked, eaten, or applied, each method of delivery loses a significant percentage of medicinal or...
A new study suggests CBD could play a role in fighting antibiotic-resistant bacteria. Many U.S. cannabis advocates say it’s further evidence that legal barriers to cannabis research need to come down — and fast.
Amid all the utopian sensationalism about the supposedly salubrious properties of the cannabinoid CBD, some are...
U.S, MARIJUANA BUSINESS DAILY (20 June 21) Recreational marijuana makes the most headlines, but a large number of cannabis consumers buy and use the plant for medical and wellness reasons.
These include acute medical conditions such as cancer, chronic pain and epilepsy, as well...